Article Information
History
- October 19, 2024.
Article Versions
- You are currently viewing Version 1 of this article (October 19, 2024 - 20:37).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gaëlle Lescuyer1,
- Alexandre Harlé2,
- Hari Shankar Kumar3,
- Pantelis Constantoulakis4,
- Nicole Pfarr5,
- Ellen Heitzer6,
- Clémence Michon7,
- Gianluca Russo8,
- Ernst-Jan M Speel10,11,
- Marie Piecyk1,
- Marie Husson2,
- Georgia Christopoulou4,
- Eva-Maria Mayr5,
- Mai-Lan Koppermann5,
- Christophe Passot7,
- Ricarda Graf6,
- Anes Hadjadj Aoul9,
- Violaine Bourdon9,
- Hendrikus J Dubbink10,
- Ronald van Marion10,
- Imke Demers11,
- Anne-Marie C Dingemans12,
- Giancarlo Troncone8,
- Francesco Pepe8,
- Laura Muinelo-Romay13,
- Ángel Díaz-Lagares14,15,16,
- Aitor Rodriguez-Casanova14,15,
- Ramón Manuel Lago Lestón13,
- Deepak Pathak3,
- Parth Shah3,
- Romain V Parillaud17,
- Oskar Martínez de Ilarduya17,
- Jonas Behr17,
- Alexis Rapin17,
- Thomas Vetterli17,
- Sanga Mitra Boppudi17,
- Umberto Malapelle8 and
- Lea Payen-Gay1,*
- 1University of Lyon 1 (UCBL1), Institute of Pharmaceutical and Biological Sciences (ISPB), Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Laboratoire de Biologie Médicale Multi-Sites (LBMMS) - Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France
- 2Biopathology Department, Institut de Cancérologie de Lorraine-Alexis Vautrin, CNRS UMR7039 CRAN Université de Lorraine, 54519 Vandœuvre-lès-Nancy, France
- 3Neuberg Centre for Genomic Medicine (NCGM), Ahmedabad, 380059, Gujarat, India
- 4Genotypos-Science Labs, 11528 Athens, Greece
- 5Institute of Pathology, School of Medicine and Health, Technical University Munich, 81675, Munich, Germany
- 6Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, 8010, Graz, Austria
- 7Institut de Cancérologie de l’Ouest, laboratoire d’Oncopharmacologie et pharmacogénétique, 49055, Angers, France
- 8Department of Public Health, Università degli Studi di Napoli-AOU Federico II, 80131, Naples, Italy
- 9Laboratoire d’Oncogénétique Moléculaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Aix-Marseille Université, F-13273 Marseille, France
- 10Department of Pathology and Clinical Bioinformatics, Erasmus Medical Center Cancer Institute, 3015 GD Rotterdam, the Netherlands
- 11Department of Pathology, GROW- Research institute for Oncology and Reproduction, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
- 12Department of Respiratory Medicine, Erasmus Medical Center Cancer Institute, 3015 GD Rotterdam, the Netherlands
- 13Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), CIBERONC, ES15706 Santiago de Compostela, Spain
- 14Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain
- 15Centro de Investigación Biomédica en Red Cáncer (CIBERONC), ISCIII, 28029 Madrid, Spain
- 16Department of Clinical Analysis, University Hospital Complex of Santiago de Compostela (CHUS), 15706 Santiago de Compostela, Spain
- 17Hedera Dx, 1066 Epalinges, Switzerland
- ↵* Corresponding author; email: lea.payen-gay{at}chu-lyon.fr